Preventing opioid use disorder in at-risk individuals
CTN-139 - Subthreshold Opioid Use Disorder Prevention (CoCare)
This study is all about helping people who might be at risk of developing problems with opioid use by offering them support, education, and resources to keep them healthy and prevent those issues from getting worse.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Oregon Health & Science University NIH-funded |
| Lab location | 1 site (Portland, United States) |
| Project ID | NIH-11295202 on NIH RePORTER |
What this research studies
This research focuses on preventing the development of opioid use disorder in individuals who may be at risk. It employs a community-based approach to identify and support those with subthreshold symptoms of opioid use disorder, providing them with resources and interventions to reduce their risk. The program aims to engage participants through education, counseling, and support services tailored to their needs. By addressing the issue early, the research seeks to mitigate the potential progression to full-blown opioid use disorder.
Who could benefit from this research
Good fit: Ideal candidates for participation are individuals who exhibit early signs of opioid use disorder or are at risk due to various factors such as previous substance use or environmental influences.
Not a fit: Patients who are already diagnosed with opioid use disorder or those who do not exhibit any risk factors for developing the disorder may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly reduce the incidence of opioid use disorder among at-risk populations.
How similar studies have performed: Previous research has shown that early intervention programs can effectively prevent the progression of substance use disorders, indicating a promising approach for this initiative.
Where this research is happening
Portland, United States
- Oregon Health & Science University — Portland, United States (Active)
Researchers
- Principal investigator: Korthuis, Philip Todd — Oregon Health & Science University
- Study coordinator: Korthuis, Philip Todd
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.